These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37433315)

  • 1. Risk of Severe Maternal Morbidity in Patients with Placenta Accreta Spectrum Disorders Referred from Rural Communities to a Regional Placenta Accreta Spectrum Center.
    Munoz JL; Ramsey PS; Byrne JJ
    Am J Perinatol; 2023 Dec; 40(16):1738-1744. PubMed ID: 37433315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder.
    Han X; Guo Z; Yang X; Yang H; Ma J
    JAMA Netw Open; 2022 Aug; 5(8):e2228002. PubMed ID: 35994286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of care for women with placenta accreta spectrum.
    Couret M; Huang Y; Khoury-Collado F; Friedman A; Hou JY; St Clair CM; Tergas AI; Ananth CV; Wright JD
    J Matern Fetal Neonatal Med; 2021 Oct; 34(20):3370-3376. PubMed ID: 31744356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of a False-Positive Antenatal Diagnosis of Placenta Accreta Spectrum.
    Salmanian B; Shamshirsaz AA; Fox KA; Asl NM; Erfani H; Detlefs SE; Coburn M; Espinoza J; Nassr A; Belfort MA; Clark SL; Shamshirsaz AA
    Am J Perinatol; 2024 Jan; 41(2):187-192. PubMed ID: 34666389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies.
    Munoz JL; Kimura AM; Julia J; Tunnell C; Hernandez B; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10692-10697. PubMed ID: 36521848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes of pregnant women with placenta accreta spectrum in Italy: A prospective population-based cohort study.
    Ornaghi S; Maraschini A; Donati S;
    PLoS One; 2021; 16(6):e0252654. PubMed ID: 34086797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal-occult placenta accreta: a clandestine source of maternal morbidity.
    Larish A; Horst K; Brunton J; Schenone M; Branda M; Mehta R; Packard A; VanBuren W; Norgan A; Shahi M; Missert A; Pompeian R; Greenwood J; Theiler R
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100924. PubMed ID: 36934974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study.
    Schwickert A; van Beekhuizen HJ; Bertholdt C; Fox KA; Kayem G; Morel O; Rijken MJ; Stefanovic V; Strindfors G; Weichert A; Weizsaecker K; Braun T;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():29-40. PubMed ID: 33524163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Matsuzaki S; Vestal NL; Sangara RN; Mandelbaum RS; Matsushima K; Klar M; Ouzounian JG
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2234-2243. PubMed ID: 34622939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.
    El Gelany S; Mosbeh MH; Ibrahim EM; Mohammed M; Khalifa EM; Abdelhakium AK; Yousef AM; Hassan H; Goma K; Alghany AA; Mohammed HF; Azmy AM; Ali WA; Abdelraheim AR
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):313. PubMed ID: 31455286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS).
    Munoz JL; Pfeiffer AF; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8640-8644. PubMed ID: 34657560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta accreta spectrum disorders - detection rate and maternal outcomes following implementation of an institutional protocol.
    Karkhanis P; Ahmed I; Irani S
    J Obstet Gynaecol; 2022 Feb; 42(2):202-208. PubMed ID: 33949292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Review of Social Deprivation Index and Maternal Outcomes with Placenta Accreta Spectrum from a Single Referral Center.
    Goulding AN; Fox KA; Reed CC; Salmanian B; Shamshirsaz AA; Aagaard KM
    Am J Perinatol; 2023 Oct; 40(13):1383-1389. PubMed ID: 37364598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful multidisciplinary team management of placenta accreta spectrum disorder: A referral center model in a middle-income country.
    Muadtongon K; Rattanaburi A; Ajimakul T; Suphasynth Y; Jiamset I; Nantamongkolkul K; Suntharasaj T; Suwanrath C; Pruksanusak N; Petpichetchian C; Suksai M; Chainarong N; Sawaddisan R; Pranpanus S
    Int J Gynaecol Obstet; 2024 May; 165(2):813-822. PubMed ID: 38189162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum.
    Mulhall JC; Ireland KE; Byrne JJ; Ramsey PS; McCann GA; Munoz JL
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674323
    [No Abstract]   [Full Text] [Related]  

  • 20. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity.
    Rau AR; Youssefzadeh AC; Matsuzaki S; Mandelbaum RS; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol MFM; 2023 May; 5(5):100805. PubMed ID: 36774226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.